References
- Amantana A, Moulton HM, Cate ML, et al. (2007). Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug Chem 18:1325–31.
- Bechara C, Sagan S. (2013). Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587:1693–702.
- Casey JR, Grinstein S, Orlowski J. (2010). Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol 11:50–61.
- Crombez L, Morris MC, Dufort S, et al. (2009). Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res 37:4559–69.
- Delaroche D, Aussedat B, Aubry S, et al. (2007). Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag. Anal Chem 79:1932–8.
- Delehanty JB, Bradburne CE, Boeneman K, et al. (2010). Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol 2:265–77.
- Deshayes S, Konate K, Aldrian G, et al. (2011). Interactions of amphipathic CPPs with model membranes. Methods Mol Biol 683:41–56.
- Elliott G, O’Hare P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223–33.
- Elmquist A, Lindgren M, Bartfai T, Langel U. (2001). VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269:237–44.
- El-Sayed A, Futaki S, Harashima H. (2009). Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J 11:13–22.
- Futaki S, Suzuki T, Ohashi W, et al. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836–40.
- Gautam A, Singh H, Tyagi A, et al. (2012). CPPsite: a curated database of cell penetrating peptides. Database: J Biol Databases Curation 2012:bas015.
- Green M, Loewenstein PM. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179–88.
- Hällbrink M, Kilk K, Elmquist A, et al. (2005). Prediction of cell-penetrating peptides. Int J Pept Res Ther 11:249–59.
- Hariton-Gazal E, Feder R, Mor A, et al. (2002). Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41:9208–14.
- Hopp TP, Woods KR. (1981). Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78:3824–8.
- Jiao C-Y, Delaroche D, Burlina F, et al. (2009). Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem 284:33957–65.
- Klonis N, Sawyer WH. (1996). Spectral properties of the prototropic forms of fluorescein in aqueous solution. J Fluoresc 6:147–57.
- Lopes LB, Brophy CM, Flynn CR, et al. (2010). A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model. J Vasc Surg 52:1596–607.
- Madani F, Lindberg S, Langel U, et al. (2011). Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys 2011:414729.
- Milletti F. (2012). Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–60.
- Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63.
- Mueller J, Kretzschmar I, Volkmer R, Boisguerin P. (2008). Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjug Chem 19:2363–74.
- Myrberg H, Zhang L, Mäe M, Langel U. (2008). Design of a tumor-homing cell-penetrating peptide. Bioconjug Chem 19:70–5.
- Röckendorf N, Bade S, Hirst TR, et al. (2007). Synthesis of a fluorescent ganglioside GM1 derivative and screening of a synthetic peptide library for GM1 binding sequence motifs. Bioconjug Chem 18:573–8.
- Sarko D, Beijer B, Boy RG, et al. (2010). The pharmacokinetics of cell-penetrating peptides. Mol Pharm 7:2224–31.
- Scheller A, Oehlke J, Wiesner B, et al. (1999). Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Peptide Sci 5:185–94.
- Stalmans S, Wynendaele E, Bracke N, et al. (2013). Chemical-functional diversity in cell-penetrating peptides. PLoS One 8:e71752.
- Ter-Avetisyan G, Tünnemann G, Nowak D, et al. (2009). Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem 284:3370–8.
- Thomas JA, Buchsbaum RN, Zimniak A, Racker E. (1979). Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18:2210–8.
- Wender PA, Mitchell DJ, Pattabiraman K, et al. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 97:13003–8.
- Zhang R, Zheng N, Song Z, et al. (2014). The effect of side-chain functionality and hydrophobicity on the gene delivery capabilities of cationic helical polypeptides. Biomaterials 35:3443–54.